Aquestive Therapeutics (AQST) EBT Margin (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly EBT Margin of 55.77% for Q1 2026, up 20719.0% year-over-year from N/an in Q1 2025, and down 153.55% quarter-over-quarter from 104.14% in Q4 2025.
Aquestive Therapeutics (AQST) EBT Margin (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' EBT Margin history runs 10 years deep, the most recent figure standing at 55.77% for Q1 2026.
- In Q1 2026, EBT Margin rose 20719.0% year-over-year to 55.77%; the TTM figure through Mar 2026 stood at 1034.08% (down 93403.0% YoY), while the FY2025 annual figure was 8932.2%, down 885549.0% from the prior year.
- EBT Margin for Q1 2026 stood at 55.77%, down from 104.14% in the prior quarter.
- The five-year high for EBT Margin was 104.14% in Q4 2025, with the low at 262.96% in Q1 2025.
- The 5-year median for EBT Margin is 106.43% (2024), against an average of 82.5%.
- The sharpest annual moves came in 2022 and 2024: EBT Margin soared 41458 bps in 2022, then plunged 17889 bps in 2024.
- Aquestive Therapeutics' EBT Margin stood at 115.63% in 2022, then jumped by 48 bps to 60.65% in 2023, then sank by 137 bps to 143.84% in 2024, then jumped by 172 bps to 104.14% in 2025, then tumbled by 154 bps to 55.77% in 2026.
- Business Quant data shows AQST's EBT Margin at 55.77% in Q1 2026, 104.14% in Q4 2025, and 120.61% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Aquestive Therapeutics | 552.47 Mn | 552.47 Mn | 9.80 Mn | -165.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -165.45% |
| Mar 31, 2026 | -55.77% |
| Dec 31, 2025 | 104.14% |
| Sep 30, 2025 | -120.61% |
| Jun 30, 2025 | -135.44% |
| Mar 31, 2025 | -262.96% |
| Dec 31, 2024 | -143.84% |
| Sep 30, 2024 | -84.99% |
| Jun 30, 2024 | -13.66% |
| Mar 31, 2024 | -106.43% |
| Dec 31, 2023 | -60.65% |
| Sep 30, 2023 | -16.73% |
| Jun 30, 2023 | -41.60% |
| Mar 31, 2023 | 72.46% |
| Dec 31, 2022 | -115.63% |
| Sep 30, 2022 | -109.36% |
| Jun 30, 2022 | -203.78% |
| Mar 31, 2022 | -107.74% |
| Dec 31, 2021 | -261.28% |
| Sep 30, 2021 | -109.54% |